136 related articles for article (PubMed ID: 28345832)
1. Metformin Inhibits Migration and Invasion of Cholangiocarcinoma Cells.
Trinh SX; Nguyen HT; Saimuang K; Prachayasittikul V; Chan On W
Asian Pac J Cancer Prev; 2017 Feb; 18(2):473-477. PubMed ID: 28345832
[TBL] [Abstract][Full Text] [Related]
2. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
[TBL] [Abstract][Full Text] [Related]
3. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
[TBL] [Abstract][Full Text] [Related]
4. Anoikis-resistant cholangiocarcinoma cells display aggressive characteristics and increase STAT3 activation.
Huyen NT; Prachayasittikul V; Chan-On W
J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):397-405. PubMed ID: 27107220
[TBL] [Abstract][Full Text] [Related]
5. All-trans retinoic acid inhibits proliferation, migration, invasion and induces differentiation of hepa1-6 cells through reversing EMT in vitro.
Cui J; Gong M; He Y; Li Q; He T; Bi Y
Int J Oncol; 2016 Jan; 48(1):349-57. PubMed ID: 26548461
[TBL] [Abstract][Full Text] [Related]
6. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition.
Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L
J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591
[TBL] [Abstract][Full Text] [Related]
7. Metformin upregulates E-cadherin and inhibits B16F10 cell motility, invasion and migration.
Liang G; Ding M; Lu H; Cao NA; Niu Y; Gao Y; Lu J
Oncol Lett; 2015 Sep; 10(3):1527-1532. PubMed ID: 26622703
[TBL] [Abstract][Full Text] [Related]
8. Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells.
Cheng K; Hao M
Int J Mol Sci; 2016 Nov; 17(12):. PubMed ID: 27916907
[TBL] [Abstract][Full Text] [Related]
9. Solamargine inhibits the migration and invasion of HepG2 cells by blocking epithelial-to-mesenchymal transition.
Xie X; Zhu H; Zhang J; Wang M; Zhu L; Guo Z; Shen W; Wang D
Oncol Lett; 2017 Jul; 14(1):447-452. PubMed ID: 28693190
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits epithelial-mesenchymal transition of oral squamous cell carcinoma via the mTOR/HIF-1α/PKM2/STAT3 pathway.
Yin W; Liu Y; Liu X; Ma X; Sun B; Yu Z
Oncol Lett; 2021 Jan; 21(1):31. PubMed ID: 33262823
[TBL] [Abstract][Full Text] [Related]
11. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
Zhang C; Guo F; Xu G; Ma J; Shao F
Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
[TBL] [Abstract][Full Text] [Related]
12. Cucurbitacin C as an effective anti-cancer agent: unveiling its potential role against cholangiocarcinoma and mechanistic insights.
Chen W; Liu Q; Huang Z; Le C; Wang Y; Yang J
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13123-13136. PubMed ID: 37474681
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
14. Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway.
Daya M; Loilome W; Techasen A; Thanee M; Sa-Ngiamwibool P; Titapun A; Yongvanit P; Namwat N
Onco Targets Ther; 2018; 11():395-408. PubMed ID: 29403285
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits the migration and invasion of esophageal squamous cell carcinoma cells by downregulating the protein kinase B signaling pathway.
He Y; Tan X; Hu H; Wang Q; Hu X; Cai X; Guan Y; Chen B; Jing X
Oncol Lett; 2018 Mar; 15(3):2939-2945. PubMed ID: 29435022
[TBL] [Abstract][Full Text] [Related]
16. CDH3/P-Cadherin regulates migration of HuCCT1 cholangiocarcinoma cells.
Baek S; Lee YW; Yoon S; Baek SY; Kim BS; Oh SO
Anat Cell Biol; 2010 Jun; 43(2):110-7. PubMed ID: 21189991
[TBL] [Abstract][Full Text] [Related]
17. Nitidine chloride suppresses epithelial-to-mesenchymal transition in osteosarcoma cell migration and invasion through Akt/GSK-3β/Snail signaling pathway.
Cheng Z; Guo Y; Yang Y; Kan J; Dai S; Helian M; Li B; Xu J; Liu C
Oncol Rep; 2016 Aug; 36(2):1023-9. PubMed ID: 27279040
[TBL] [Abstract][Full Text] [Related]
18. Magnolin inhibits cell migration and invasion by targeting the ERKs/RSK2 signaling pathway.
Lee CJ; Lee MH; Yoo SM; Choi KI; Song JH; Jang JH; Oh SR; Ryu HW; Lee HS; Surh YJ; Cho YY
BMC Cancer; 2015 Aug; 15():576. PubMed ID: 26253302
[TBL] [Abstract][Full Text] [Related]
19. Metformin inhibits the radiation-induced invasive phenotype of esophageal squamous cell carcinoma.
Nakayama A; Ninomiya I; Harada S; Tsukada T; Okamoto K; Nakanuma S; Sakai S; Makino I; Kinoshita J; Hayashi H; Oyama K; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T
Int J Oncol; 2016 Nov; 49(5):1890-1898. PubMed ID: 27599468
[TBL] [Abstract][Full Text] [Related]
20. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways.
Pan Q; Yang GL; Yang JH; Lin SL; Liu N; Liu SS; Liu MY; Zhang LH; Huang YR; Shen RL; Liu Q; Gao JX; Bo JJ
J Exp Clin Cancer Res; 2015 Aug; 34(1):77. PubMed ID: 26245871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
